KAI BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,340 KRW | -.--% |
|
-.--% | -71.18% |
| 6 months | -71.18% | ||
| Current year | -71.18% |
| 3 months | -18.72% | ||
| 6 months | -71.18% | ||
| Current year | -71.18% |
Current year
6 340.00
18 700.00
1 year
6 340.0024 600.00
3 years
6 340.0024 600.00
5 years
6 340.0024 600.00
10 years
6 340.0024 600.00
| Managers | Title | Age | Since |
|---|---|---|---|
Young-Deok Kim
CEO | Chief Executive Officer | 52 | 30/11/12 |
Sun-Hee Kim
AUD | Comptroller/Controller/Auditor | 68 | 31/07/14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Young-Deok Kim
CEO | Chief Executive Officer | 52 | 30/11/12 |
Young-Kyun Jung
BRD | Director/Board Member | 51 | 30/06/17 |
Seok-Tae Im
BRD | Director/Board Member | 58 | 30/11/12 |
Kai BioTech Co Ltd is a Korea-based company mainly engaged in the medical business based on radioactive fusion technology. The Company is engaged in the manufacture and sale of radiopharmaceuticals used in the diagnosis of oncology, prostate, liver, lung and brain cancers as well as others. The Company is also engaged in the manufacture and sale of pheochromocytoma treatment, liver cancer treatment and other products.
| 1st Jan change | Capi. | |
|---|---|---|
| -71.18% | 4.56M | |
| +29.41% | 49.18B | |
| +0.63% | 42.11B | |
| +50.47% | 40.37B | |
| -5.26% | 28.85B | |
| +13.68% | 26.09B | |
| -22.78% | 18.71B | |
| +8.19% | 13.26B | |
| +32.95% | 12.32B | |
| -1.37% | 11.99B |
- Stock Market
- Equities
- A446600 Stock
